Goals
Preventative Care
Drug Therapy
Insulin
Miscellaneous
100

Per 2020 ADA guidelines:

Goal A1C = ___

<7%

100

How often should patients with diabetes get an eye exam?

- DMT2: At diagnosis & annually 

- DMT1: Within 5 years after Dx of DM. 

100

Mention 1 MOA and 1 monitoring parameters of Metformin?

~MOA: Prevents gluconeogenesis/glycolysis, increases GLP-1 secretion, inhibits lipid and cholesterol synthesis; also, decrease intestinal glucose absorption

~Monitor: SCr, B12. Also, Lactate if concern for lactic acidosis. 

100

When would you initiate insulin therapy?

~T1DM

~T2DM: Catabolic, symptomatic hyperglycemia or A1C >10% or glycemia > 300 mg/dL

100

Name 2 microvascular complications with diabetes

1) Retinopathy

2) Nephropathy

3) Neuropathy

200

Per 2020 ADA guidelines:

For elderly (76 yo) with HF, CKD stage 4 and COPD, what is the HbA1c % goal = _____

< 7.5 to 8.5, life expectancy < 10 years. 

200

Name one exam that patients with diabetes should do daily and why (to prevent what?)

~Check feet 

~Why? Diabetic Foot Infection (DFI)

200

Name two GLP1-RA with CV protective properties 

1) Liraglutide

2) Semaglutide

200

Complications of insulin use:

- Hypoglycemia, weight gain, lipohyperthrophy, infection in injection site...

200

Name 2 macrovascular complications with diabetes

1) Cerebrovascular disease

2) Cardiovascular disease

3) Peripheral arterial disease

4) Impaired wound healing

300

Per 2020 ADA guidelines:

BP goal for diabetic patient = ____

<130/80 mmHg, if can be safely achieved and avoid symptomatic hypotension

300

Recommended screening for Albuminuria in patients with DMT2: ______

At least annually. If > 30 mg/g Cr or eGFR < 60 ml/min/1.73 m2, should be monitored twice annually. 

300

Name two classes of drugs that should be avoided in patients who are obese and trying to lose weight

1) SFU/Meglitinides

2) Insulin (unless symptomatic from hyperglycemia)

300

Mention type of basal insulin formulation

- Glargine: Lantus or Toujeo (~36 hrs) 

- Detemir: Levemir 

- Degludec: Tresiba (up to 42 hours).

300

What are 4 examples of when a patient should call their doctor regarding their diabetes while they are sick?


1) Glucose remains >300 mg/dL for more than 6 hours or <70 mg/dL after repeated treatment

2) Vomiting and diarrhea for more than 6 hours

3) Dehydrated

4) Confusion, sleepiness, seizures

400

Patient presents with BP of 165/100 mmHG and Alb/Cr=40.

Per 2020 ADA guidelines, would you start this patient on HTN therapy? If so, give specific recommendation including drug(s) or drug classes.

ACE-I or ARB 

+

CCB or diuretic  

400

Recommended minimum time of moderate intensity physical activity per week: 

At least 150 min/week of moderate exertion (walking, stain climbing). Increased as tolerated. 

400

When should provider’s avoid prescribing SGLT-2 inhibitors for therapy?


~ Hx of urinary incontinence or frequent UTIs

~ Amputations risk (foot ulcers, PAD, osteoporosis)

~ Risk of DKA (acute illness, eating disorders, ETOH)

400

Mechanism of action by which Sulfonylureas increase insulin secretion?

Blockage of ATP-sensitive K channels of Beta cells in pancreas, facilitating depolarization and release of insulin. 

400

What are 3 appropriate food/drink options to manage a hypoglycemic event?

~4 glucose tablets

~1 tube of glucose gel

~8 oz of milk

~4 oz of juice

~4 oz regular soda

~2 sugar packets

~15 skittles 

500

Per 2020 ADA guidelines, what is the recommended Pre-prandial capillary plasma glucose goal: _______.

(Not pregnant, young, and otherwise healthy individuals)

80-130 mg/dL


500

Name 3 immunizations indicated for patients with diabetes. 

1) PPSV23

2) Influenza

3) Hepatitis B

500

Which oral anti-diabetic drugs should be discontinued if patient has HF NYHA III-IV? And why?

1) Thiazolidinediones. Because of concern for fluid retention and worsening HF. 

500

Calculate a TDD, basal dose, and bolus dose of insulin naive patient who weighs 90 kg:

TDD: 30 units

Basal: 15 units

Bolus: ~5 units before each meal

500

Name 1 contraindications of GLP-1 Receptor agonists

1-  Personal or family of Medullary Thyroid Carcinoma Thyroid C-cell tumor) or MEN type 2

M
e
n
u